Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel

Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel

Combinatorial therapeutic strategies to eradicate tumors can be superior to a single therapeutic modality. Docetaxel (DT) has been approved for the treatment of local or metastasized breast cancer alone or in combination with other chemotherapeutic agents. Thymoquinone (TQ) originated from the seeds...

Full description

Bibliographic Details
Main Authors: Fadwa Odeh, Randa Naffa, Hanan Azzam, Ismail S. Mahmoud, Walhan Alshaer, Abeer Al Bawab, Said Ismail
Format: Article
Language:English
Published: Elsevier 2019-11-01
Series:Heliyon
Subjects:
Cancer research
Pharmaceutical science
Breast cancer
Docetaxel
Thymoquinone
Liposomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844019365788

Internet

http://www.sciencedirect.com/science/article/pii/S2405844019365788

Similar Items